In 2023, the share of corresponding/leading authors in scientific publications in the biomedical engineering sector in the U.S. stood at 94.59%. The forecasted data from 2024 to 2028 indicates a slight downward trend with values moving from 94.58% to 94.52%, showing a minimal change each year. The year-on-year variation is nearly negligible, indicating a stable distribution of corresponding authorship roles. Over a longer period from 2024 to 2028, the compound annual growth rate (CAGR) reflects a marginal decline, suggesting stability with a slight inclination towards decentralizing authorship roles.
Future trends to watch for include potential shifts driven by international collaborations, increasing diversity in research teams, and evolving academic dynamics that may affect the roles and responsibilities of corresponding authors in this field.
